From Financial Modeling Prep: 2025-06-18 14:00:00

Aurora Cannabis Inc. (NASDAQ: ACB, TSX: ACB) missed earnings expectations with an EPS of -$0.24, below the estimated $0.11. Actual revenue was $63.3 million, falling short of the projected $88.9 million.

Aurora Cannabis Inc. is a prominent global medical cannabis company headquartered in Canada. Despite financial challenges, Aurora competes with industry leaders like Tilray and Canopy Growth. Strategic shifts and financial management are key to their path towards profitability.

On June 18, 2025, Aurora reported an EPS of -$0.24, missing the estimated $0.11. Actual revenue was approximately $63.3 million, lower than the expected $88.9 million.

Aurora’s financial metrics present a mixed picture. The P/E ratio is around 41.17, reflecting investor confidence in future earnings. However, the enterprise value to operating cash flow ratio is -40.01, indicating challenges in generating positive cash flow. With a current ratio of 3.30, Aurora maintains strong liquidity to meet short-term obligations.



Read more at Financial Modeling Prep:: Aurora Cannabis Inc. (NASDAQ: ACB, TSX: ACB) Finan…